Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D James Nokes

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Science (New York, N.Y.)|July 18, 2009
Epidemiology. Does viral diversity matter?Graham F Medley, D James Nokes
Proceedings. Biological Sciences|February 13, 2002
On the determinants of population structure in antigenically diverse pathogensM Gabriela M Gomes, Graham F Medley, D James Nokes
Plos One|January 10, 2013
The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan childrenEmelda A Okiro, Mwanajuma Ngama, Ann Bett, et al.
Wellcome Open Research|September 28, 2020
Accuracy of diagnostic tests for respiratory syncytial virus infection within a paediatric hospital population in Kilifi County, KenyaMarshal M Mweu, Nickson Murunga, Juliet W Otieno, et al.
Wellcome Open Research|January 10, 2017
Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household studyMiriam Wathuo, Graham F Medley, D James Nokes, et al.
Vaccine|February 20, 2007
Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedulesJamie N Wilson, D James Nokes, Graham F Medley, et al.
Journal of Clinical Microbiology|July 22, 2011
Improved detection of respiratory viruses in pediatric outpatients with acute respiratory illness by real-time PCR using nasopharyngeal flocked swabsPatrick Kiio Munywoki, Fauzat Hamid, Martin Mutunga, et al.
Vaccine: X|March 4, 2020
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country settingTimothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, et al.
Epidemics|December 29, 2018
Model-based estimates of transmission of respiratory syncytial virus within householdsIvy K Kombe, Patrick K Munywoki, Marc Baguelin, et al.
The Journal of Infectious Diseases|November 24, 2012
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaCharles J Sande, Martin N Mutunga, Graham F Medley, et al.
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Science (New York, N.Y.)|July 18, 2009
Epidemiology. Does viral diversity matter?Graham F Medley, D James Nokes
Proceedings. Biological Sciences|February 13, 2002
On the determinants of population structure in antigenically diverse pathogensM Gabriela M Gomes, Graham F Medley, D James Nokes
Plos One|January 10, 2013
The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan childrenEmelda A Okiro, Mwanajuma Ngama, Ann Bett, et al.
Wellcome Open Research|September 28, 2020
Accuracy of diagnostic tests for respiratory syncytial virus infection within a paediatric hospital population in Kilifi County, KenyaMarshal M Mweu, Nickson Murunga, Juliet W Otieno, et al.
Wellcome Open Research|January 10, 2017
Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household studyMiriam Wathuo, Graham F Medley, D James Nokes, et al.
Vaccine|February 20, 2007
Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedulesJamie N Wilson, D James Nokes, Graham F Medley, et al.
Journal of Clinical Microbiology|July 22, 2011
Improved detection of respiratory viruses in pediatric outpatients with acute respiratory illness by real-time PCR using nasopharyngeal flocked swabsPatrick Kiio Munywoki, Fauzat Hamid, Martin Mutunga, et al.
Vaccine: X|March 4, 2020
Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country settingTimothy Kinyanjui, Wirichada Pan-Ngum, Sompob Saralamba, et al.
Epidemics|December 29, 2018
Model-based estimates of transmission of respiratory syncytial virus within householdsIvy K Kombe, Patrick K Munywoki, Marc Baguelin, et al.
The Journal of Infectious Diseases|November 24, 2012
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaCharles J Sande, Martin N Mutunga, Graham F Medley, et al.
Pageof 14